Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Operating Leases (2022 - 2026)

Invivyd's (IVVD) quarterly Operating Leases came in at $6.8 million in Q2 2026, up 257.89% on a YoY basis from $1.9 million in Q2 2025, and up 476.27% quarter-over-quarter from $1.2 million in Q4 2025.

Analysis

Invivyd (IVVD) Operating Leases (2022 - 2026) Analysis & Trends

Invivyd (IVVD) has reported Operating Leases for 5 consecutive years, with $6.8 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Operating Leases rose 257.89% year-over-year to $6.8 million; the trailing twelve-month figure through Jun 2026 stood at $6.8 million (up 257.89% YoY), and the FY2025 full-year result was $1.2 million, down 32.22% from the prior year.
  • Operating Leases rose to $6.8 million in Q2 2026 per IVVD's latest filing, from $1.2 million in the prior quarter.
  • Across five years, Operating Leases topped out at $6.8 million in Q2 2026 and bottomed at $100000.0 in Q1 2022.
  • Historically, Operating Leases has averaged $1.5 million across 5 years, with a median of $1.3 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Operating Leases slumped 76.38% in 2024, then soared 630.59% in 2025.
  • Over 5 years, Operating Leases stood at $2.2 million in 2022, then dropped by 20.05% to $1.7 million in 2023, then climbed by 0.58% to $1.7 million in 2024, then slumped by 32.22% to $1.2 million in 2025, then surged by 476.27% to $6.8 million in 2026.
  • According to Business Quant data, Operating Leases over the past three periods registered $6.8 million, $1.2 million, and $1.6 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.80 Mn
Dec 31, 2025 1.18 Mn
Sep 30, 2025 1.60 Mn
Jun 30, 2025 1.90 Mn
Mar 31, 2025 425,000.00
Dec 31, 2024 1.74 Mn
Sep 30, 2024 219,000.00
Mar 31, 2024 435,000.00
Dec 31, 2023 1.73 Mn
Sep 30, 2023 927,000.00
Jun 30, 2023 1.35 Mn
Mar 31, 2023 432,000.00
Dec 31, 2022 2.17 Mn
Sep 30, 2022 1.20 Mn
Jun 30, 2022 1.90 Mn
Mar 31, 2022 100,000.00